Delafloxacin
CAS 189279-58-1Small Molecule
Overview
Delafloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105637).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Delafloxacin expires 2 Jun 2034 and exclusivity 19 Jun 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid
- Canonical SMILES
- C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O
- InChIKey
- DYDCPNMLZGFQTM-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Delafloxacin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.